Elaine K. Sorg's Insider Trades & SAST Disclosures
Elaine K. Sorg's most recent trade in Abbvie Inc was a trade of 6,130 Common Stock, $0.01 par value done at an average price of $165 . Disclosure was reported to the exchange on April 25, 2023.
Add Superstar Alert
Note
This is a custom search result for pattern Elaine K. Sorg.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 165.00 per share. | 25 Apr 2023 | 6,130 | 35,330 (0%) | 0% | 165 | 1,011,450 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2023 | 6,130 | 12,258 | - | - | Option (Right to Buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.54 per share. | 25 Apr 2023 | 6,130 | 41,460 (0%) | 0% | 144.5 | 886,030 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 161.64 per share. | 17 Apr 2023 | 6,999 | 35,830 (0%) | 0% | 161.6 | 1,131,318 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 162.04 per share. | 17 Apr 2023 | 500 | 35,330 (0%) | 0% | 162.0 | 81,020 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 160.03 per share. | 03 Apr 2023 | 15,002 | 42,829 (0%) | 0% | 160.0 | 2,400,770 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 15,002 | 0 | - | - | Option (Right to Buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.50 per share. | 03 Apr 2023 | 15,002 | 57,831 (0%) | 0% | 93.5 | 1,402,687 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.28 per share. | 28 Feb 2023 | 19,850 | 42,829 (0%) | 0% | 154.3 | 3,062,458 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.50 per share. | 28 Feb 2023 | 15,003 | 57,832 (0%) | 0% | 93.5 | 1,402,781 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 28 Feb 2023 | 15,003 | 42,829 (0%) | 0% | 155 | 2,325,465 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 15,003 | 0 | - | - | Option (Right to Buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 29,410 | 47,286 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 15,321 | 7,660 | - | - | Option (Right to Buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.92 per share. | 16 Feb 2023 | 15,321 | 78,000 (0%) | 0% | 105.9 | 1,622,800 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 13,166 | 13,166 | - | - | Option (Right to Buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 151.29 per share. | 16 Feb 2023 | 8,420 | 62,679 (0%) | 0% | 151.3 | 1,273,862 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 150.74 per share. | 16 Feb 2023 | 6,901 | 71,099 (0%) | 0% | 150.7 | 1,040,257 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 6,861 | 54,147 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 4,658 | 58,805 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 3,874 | 62,679 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.54 per share. | 25 Feb 2022 | 11,125 | 24,360 (0%) | 0% | 149.5 | 1,663,633 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 148.59 per share. | 25 Feb 2022 | 3,451 | 18,576 (0%) | 0% | 148.6 | 512,783 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 147.59 per share. | 25 Feb 2022 | 2,333 | 22,027 (0%) | 0% | 147.6 | 344,333 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 149.07 per share. | 25 Feb 2022 | 700 | 17,876 (0%) | 0% | 149.1 | 104,351 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 18,388 | 18,388 | - | - | Option (Right to Buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 11,642 | 11,642 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 10,377 | 35,485 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 6,861 | 21,033 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 4,075 | 25,108 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,530 | 14,172 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.15 per share. | 10 Dec 2021 | 5,137 | 6,458 (0%) | 0% | 124.2 | 637,759 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 125.85 per share. | 10 Dec 2021 | 3,229 | 3,229 (0%) | 0% | 125.9 | 406,370 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 125.85 per share. | 10 Dec 2021 | 3,229 | 0 (0%) | 0% | 125.9 | 406,370 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 7,080 | 0 | - | - | Option (Right to buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 23 Aug 2021 | 7,080 | 11,595 (0%) | 0% | 120 | 849,600 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.36 per share. | 23 Aug 2021 | 7,080 | 18,675 (0%) | 0% | 114.4 | 809,669 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 23 Aug 2021 | 6,000 | 11,595 (0%) | 0% | 120 | 720,000 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.74 per share. | 28 Feb 2021 | 6,716 | 26,035 (0%) | 0% | 107.7 | 723,582 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 108.61 per share. | 28 Feb 2021 | 4,221 | 17,595 (0%) | 0% | 108.6 | 458,437 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 108.61 per share. | 28 Feb 2021 | 4,219 | 21,816 (0%) | 0% | 108.6 | 458,205 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 104.71 per share. | 22 Feb 2021 | 19,995 | 32,951 (0%) | 0% | 104.7 | 2,093,676 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 15,003 | 30,005 | - | - | Option (right to buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.50 per share. | 22 Feb 2021 | 15,003 | 47,754 (0%) | 0% | 93.5 | 1,402,781 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 5,192 | 5,192 | - | - | Option (right to buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.02 per share. | 22 Feb 2021 | 5,192 | 52,946 (0%) | 0% | 79.0 | 410,272 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Sale of securities on an exchange or to another person at price $ 105.28 per share. | 22 Feb 2021 | 200 | 32,751 (0%) | 0% | 105.3 | 21,056 | Common Stock, $0.01 par value |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 22,981 | 22,981 | - | - | Option (right to buy) | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 6,863 | 32,751 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
|
Abbvie Inc
|
Elaine K. Sorg | SVP, US Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 4,454 | 22,049 (0%) | 0% | 0 | Common Stock, $0.01 par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges